Prognostic Factors in Stereotactic Body Radiotherapy for Non–Small-Cell Lung Cancer
- 1 March 2011
- journal article
- research article
- Published by Elsevier in International Journal of Radiation Oncology*Biology*Physics
- Vol. 79 (4) , 1104-1111
- https://doi.org/10.1016/j.ijrobp.2009.12.022
Abstract
No abstract availableKeywords
This publication has 38 references indexed in Scilit:
- Survey of Stereotactic Body Radiation Therapy in Japan by the Japan 3-D Conformal External Beam Radiotherapy GroupInternational Journal of Radiation Oncology*Biology*Physics, 2009
- Treatment of Non-small Cell Lung Cancer Stage I and Stage IIChest, 2007
- Hypofractionated Stereotactic Radiotherapy (HypoFXSRT) for Stage I Non-small Cell Lung Cancer: Updated Results of 257 Patients in a Japanese Multi-institutional StudyJournal of Thoracic Oncology, 2007
- Stereotactic radiotherapy for primary lung cancer and pulmonary metastases: A noninvasive treatment approach in medically inoperable patientsInternational Journal of Radiation Oncology*Biology*Physics, 2004
- Extracranial Stereotactic Radioablation *Chest, 2003
- Tolerance of organs at risk in small-volume, hypofractionated, image-guided radiotherapy for primary and metastatic lung cancersInternational Journal of Radiation Oncology*Biology*Physics, 2003
- Clinical outcomes of 3D conformal hypofractionated single high-dose radiotherapy for one or two lung tumors using a stereotactic body frameInternational Journal of Radiation Oncology*Biology*Physics, 2002
- Focal, high dose, and fractionated modified stereotactic radiation therapy for lung carcinoma patientsCancer, 1998
- Radiotherapy for patients with medically inoperable stage I nonsmall cell lung carcinomaCancer, 1998
- Stereotactic High Dose Fraction Radiation Therapy of Extracranial Tumors Using An Accelerator: Clinical experience of the first thirty-one patientsActa Oncologica, 1995